Danisco Extends Bacteria Culture Agreement

Danisco has extended its licensing agreement with Fonterra for two probiotic bacteria cultures.

Under the agreement, Danisco will produce and market Fonterra’s HOWARU Bifido and Rhamnosus probiotic strains, with the new term extending from five to ten years, the company said.

The agreement also extends Danisco’s global access to dairy products, liquid and powdered beverages, dietary supplements, meats, cheeses, cereals, confectionery and straws.

The Danish company said the deal broadens scope for the development of clinical studies and health claims.

In 2001, Danisco first began licensing Fonterra-developed probiotics which have since been developed at Fonterra’s research centre in New Zealand.